The value of mNGS in the diagnosis of central nervous system infections in immunodeficient hosts with decompensated cirrhosis complicated by Listeria encephalitis: Case Report - Report - MDSpire
Advertisement
Utilizing mNGS for Diagnosing Central Nervous System Infections in Immunocompromised Patients with Decompensated Cirrhosis and Listeria Encephalitis: A Case Study
Clinical Report: Utilizing mNGS for Diagnosing CNS Infections in Cirrhosis
Background
Central nervous system infections caused by Listeria monocytogenes are increasingly recognized, particularly in immunocompromised patients such as those with decompensated cirrhosis. The diagnostic challenges in this population are compounded by cirrhosis-associated immune dysfunction, which can obscure typical clinical markers.
Data Highlights
No numerical data or trial data was provided in the article.
Key Findings
A 62-year-old male with decompensated cirrhosis presented with fever, headache, and altered consciousness.
Conventional cerebrospinal fluid (CSF) cultures were negative, but mNGS identified Listeria monocytogenes within 16 hours.
The patient's Child-Pugh score was 9 (Grade B) and MELD score was 12 at admission.
Broad-spectrum antibiotics were initiated prior to mNGS results to avoid treatment delays.
Early mNGS-guided therapy was associated with significant clinical improvement and successful discharge.
Clinical Implications
Clinicians should consider mNGS as a diagnostic option in cases of suspected Listeria infections, especially in patients with cirrhosis.
Conclusion
mNGS provides a rapid diagnostic method for identifying CNS infections in immunocompromised patients.